Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2020 3
2021 3
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
[99mTc]Tc-iFAP/SPECT Tumor Stroma Imaging: Acquisition and Analysis of Clinical Images in Six Different Cancer Entities.
Vallejo-Armenta P, Ferro-Flores G, Santos-Cuevas C, García-Pérez FO, Casanova-Triviño P, Sandoval-Bonilla B, Ocampo-García B, Azorín-Vega E, Luna-Gutiérrez M. Vallejo-Armenta P, et al. Among authors: garcia perez fo. Pharmaceuticals (Basel). 2022 Jun 9;15(6):729. doi: 10.3390/ph15060729. Pharmaceuticals (Basel). 2022. PMID: 35745648 Free PMC article.
Multitarget Molecular Imaging in Metastatic Castration Resistant Adenocarcinoma Prostate Cancer with Therapy Induced Neuroendocrine Differentiation.
Vargas Ahumada J, González Rueda SD, Sinisterra Solís FA, Pitalúa Cortés Q, Torres Agredo LP, Miguel JR, Scavuzzo A, Soldevilla-Gallardo I, Álvarez Avitia MA, Sobrevilla N, García Pérez FO. Vargas Ahumada J, et al. Among authors: garcia perez fo. Diagnostics (Basel). 2022 Jun 3;12(6):1387. doi: 10.3390/diagnostics12061387. Diagnostics (Basel). 2022. PMID: 35741197 Free PMC article.
Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [177Lu]Lu-PSMA-617. A WARMTH multicenter study (the 617 trial).
Ahmadzadehfar H, Rahbar K, Baum RP, Seifert R, Kessel K, Bögemann M, Kulkarni HR, Zhang J, Gerke C, Fimmers R, Kratochwil C, Rathke H, Ilhan H, Maffey-Steffan J, Sathekge M, Kabasakal L, Garcia-Perez FO, Kairemo K, Maharaj M, Paez D, Virgolini I. Ahmadzadehfar H, et al. Among authors: garcia perez fo. Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):113-122. doi: 10.1007/s00259-020-04797-9. Epub 2020 May 8. Eur J Nucl Med Mol Imaging. 2021. PMID: 32383093 Free PMC article.
Head-to-Head Comparison of 68Ga-PSMA-11 and 131I in the Follow-Up of Well-Differentiated Metastatic Thyroid Cancer: A New Potential Theragnostic Agent.
Pitalua-Cortes Q, García-Perez FO, Vargas-Ahumada J, Gonzalez-Rueda S, Gomez-Argumosa E, Ignacio-Alvarez E, Soldevilla-Gallardo I, Torres-Agredo L. Pitalua-Cortes Q, et al. Among authors: garcia perez fo. Front Endocrinol (Lausanne). 2021 Dec 22;12:794759. doi: 10.3389/fendo.2021.794759. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 35002972 Free PMC article.
The impact of the extent of the bone involvement on overall survival and toxicity in mCRPC patients receiving [177Lu]Lu-PSMA-617: a WARMTH multicentre study.
Ahmadzadehfar H, Matern R, Baum RP, Seifert R, Kessel K, Bögemann M, Kratochwil C, Rathke H, Ilhan H, Svirydenka H, Sathekge M, Kabasakal L, Yordanova A, Garcia-Perez FO, Kairemo K, Maharaj M, Paez D, Virgolini I, Rahbar K. Ahmadzadehfar H, et al. Among authors: garcia perez fo. Eur J Nucl Med Mol Imaging. 2021 Nov;48(12):4067-4076. doi: 10.1007/s00259-021-05383-3. Epub 2021 May 25. Eur J Nucl Med Mol Imaging. 2021. PMID: 34031719
Diagnostic Performance of 99mTc-iPSMA SPECT/CT in the Initial Staging of Patients with Unfavorable Intermediate-, High-, and Very High-Risk Prostate Cancer: A Comparative Analysis with 18F-PSMA-1007 PET/CT.
Vargas-Ahumada JE, González-Rueda SD, Sinisterra-Solís FA, Casanova-Triviño P, Pitalúa-Cortés Q, Soldevilla-Gallardo I, Scavuzzo A, Jimenez-Ríos MA, García-Pérez FO. Vargas-Ahumada JE, et al. Among authors: garcia perez fo. Cancers (Basel). 2023 Dec 13;15(24):5824. doi: 10.3390/cancers15245824. Cancers (Basel). 2023. PMID: 38136369 Free PMC article.
Head to head comparison performance of 99mTc-EDDA/HYNIC-iPSMA SPECT/CT and 68Ga-PSMA-11 PET/CT a prospective study in biochemical recurrence prostate cancer patients.
García-Pérez FO, Davanzo J, López-Buenrostro S, Santos-Cuevas C, Ferro-Flores G, Jímenez-Ríos MA, Scavuzzo A, Santana-Ríos Z, Medina-Ornelas S. García-Pérez FO, et al. Am J Nucl Med Mol Imaging. 2018 Oct 20;8(5):332-340. eCollection 2018. Am J Nucl Med Mol Imaging. 2018. PMID: 30510850 Free PMC article.